This inventor holds 1 USPTO granted patent. Top assignee: Institut Fue Diagnostikforschung Gmbh. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Cornelius Frommel and Targeted Diagnostic Peptides.
Introduction
Cornelius Frommel is an inventor associated with Zeuthen, Germany, and Institut für Diagnostikforschung GmbH. His work includes a patented approach to metal-binding, cysteine-free peptides designed for diagnostic and therapeutic applications.
Latest Patents
Frommel is associated with 1 patent: “Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds.” The invention describes peptides that bind metals and can be linked to organ-specific probes, such as antibodies or antibody fragments targeting tumor-associated antigens. These conjugates are intended to accumulate selectively in tumors, organs, tissues, or sites of inflammation.
The patent also covers methods for producing the peptides and their conjugates, as well as their use in kits for in vivo diagnosis or therapy. Radioisotope-containing radiopharmaceuticals based on the conjugates are described for imaging or treating tumors, organs, and inflammatory sites.
Career Highlights
The patent reflects Frommel’s involvement in research connecting peptide chemistry with targeted medical imaging and therapy. The described technology aims to direct diagnostic or therapeutic compounds toward specific biological targets.
Collaborations
Frommel’s listed coworkers include Ludger Dinkelborg and Gabriele Kuttner. The patent describes work involving organ-specific probes and peptide conjugates, although the supplied information does not specify the individual contributions of these collaborators.
Conclusion
Cornelius Frommel’s patent focuses on metal-binding, cysteine-free peptides that can be paired with targeted probes for diagnostic imaging and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile